Safyan, R. A., Colby, S., Singh, H., Guthrie, K. A., Sun, V., Wadlow, R. C., Gbolahan, O. B., Sohal, D., Lowy, A. M., Ahmad, S. A., Chiorean, E. G., Philip, P. A. (2026). S2433: Randomized phase III study of second-line chemotherapy with or without panitumumab for KRAS wild type, locally advanced, or metastatic pancreatic adenocarcinoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps4264